Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control

Shifa International Hospital68 enrolled

Overview

The study aims to investigate the effects of Guided Meditation on diabetes-related distress and glycemic control in hospitalized Type 1 adolescent diabetic patients. The study will employ a randomized controlled trial design, with participants randomly assigned to either the intervention group (receiving Guided Meditation sessions) or the control group (receiving standard care). The primary outcomes measured will be diabetes-related distress levels and glycemic control (HbA1c levels).

The researchers hypothesize that the intervention group will experience a reduction in diabetes-related distress and an improvement in glycemic control compared to the control group. The study's findings could suggest how guided meditation could help manage the emotional distress and enhance diabetes management in hospitalized Type 1 adolescent diabetic patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Type 1 Diabetes Mellitus

Interventions

Guided meditationBEHAVIORAL

Meditation with guidance

Eligibility

Sex: ALLMin age: 12 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adolescent patients aged between 12 to 18 years. * Confirmed diagnosis of Type 1 diabetes mellitus. * Hospitalized in the participating medical facility. * Capable of providing informed consent (for participants aged 18) or providing assent with parental/legal guardian consent (for participants aged 12 to 17). Exclusion Criteria: * Presence of severe psychiatric disorders or cognitive impairments that may hinder participation in the guided meditation sessions. * Physical limitations or medical conditions that prevent the safe participation in the intervention or assessment procedures. * Previously engaged in regular meditation or mindfulness practices, which may confound the results. * Inability to communicate effectively in the language used for assessments and interventions.

Locations (1)

Shifa Hospital

Lahore, Pakistan

Outcomes

Primary Outcomes

Diabetes distress scale

Diabetes distress scale questionnaire

Time frame: Week 1 and Week 13

Secondary Outcomes

HbA1c levels

Time frame: Week 1 and Week 13

Number of hypoglycemic and hyperglycemic episodes

Time frame: Week 1, 4, 8 and 12

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.